The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the ...

Allovir Inc., which has struggled since late last December, will merge with privately held Kalaris Therapeutics Inc. to develop therapies for treating neovascular and exudative retinal diseases.

Several Philadelphia-area companies gained millions in value following Donald Trump's victory. A Philadelphia retailer, ...

As an array of developers push their Friedreich’s ataxia (FA) drugs along, PTC Therapeutics Inc.’s recent update on its program piqued thirst for the 15-lipoxygenase inhibitor vatiquinone. Warren, N.J ...

Check the time stamp on this data. Updated AI-Generated Signals for Larimar Therapeutics Inc. (LRMR) available here: LRMR.

Equities research analysts at William Blair lifted their FY2024 EPS estimates for Larimar Therapeutics in a research note ...

Analysts at HC Wainwright lifted their FY2024 earnings per share estimates for Larimar Therapeutics in a research report ...

Larimar Therapeutics, Inc. ( (LRMR) ) has realeased its Q3 earnings. Here is a breakdown of the information Larimar Therapeutics, Inc.

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has released its financial results for the third quarter of 2024, ...

Larimar Therapeutics (LRMR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Larimar Therapeutics, Inc. (Larimar) (NASDAQ: LRMR) recently announced its third-quarter 2024 operating and financial results, showcasing its progress in developing treatments for complex rare ...